Renal denervation

Anadolu Kardiyoloji Dergisi

Volumn 14, Issue 2, 2014, Pages 186-191

  Drexel, Todd ^a   Bertog, Stefan C ^b   Vaskelyte, Laura ^b   Sievert, Horst ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Cardiovascular Center   (Germany)

Author keywords

Diabetes; Heart failure; Hypertension; Renal sympathetic denervation; Sleep apnea

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENYLATE CYCLASE; ALPHA 2 ADRENERGIC RECEPTOR; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR; CREATININE; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; NEUROPEPTIDE Y; NORADRENALIN; RENIN; SUBSTANCE P;

ADRENERGIC SYSTEM; ARTICLE; ATRIOVENTRICULAR JUNCTION ARRHYTHMIA; CENTRAL NERVOUS SYSTEM; CHEMORECEPTOR; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; INTRACELLULAR SIGNALING; KIDNEY DENERVATION; KIDNEY FAILURE; KIDNEY FUNCTION; MECHANORECEPTOR; NEPHRECTOMY; OPTICAL COHERENCE TOMOGRAPHY; PREGANGLIONIC NERVE; PRESSORECEPTOR; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SLEEP DISORDERED BREATHING; SYSTOLIC BLOOD PRESSURE; VASOCONSTRICTION; INNERVATION; KIDNEY; SYMPATHECTOMY;

HUMANS; HYPERTENSION; KIDNEY; SYMPATHECTOMY;

EID: 84897385851     PISSN: None     EISSN: 13080032     Source Type: Journal    
DOI: 10.5152/akd.2014.5294     Document Type: Article

References (48)

1. Kopp UC, Cicha MZ, Smith LA. Dietary sodium loading increases arterial pressure in afferent renal-denervated rats. Hypertension 2003; 42: 968-73.[CrossRef]
2. Kopp UC, Jones SY, DiBona GF. Afferent renal denervation impairs baroreflex control of efferent renal sympathetic nerve activity. Am J Physiol Regul Integr Comp Physiol 2008; 295: 1882-90.[CrossRef]
3. Campese VM, Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension 1995; 25: 878-82.[CrossRef]
4. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992; 327: 1912-8.[CrossRef]
5. Hausberg M, Kosch M, Harmelink P, Barenbrock M, Hohage H, Kisters K, et al. Sympathetic nerve activity in end-stage renal disease. Circulation 2002; 106: 1974-9.[CrossRef]
6. Ask Upmark. Ueber juvenile maligne Nephrosclerose und ihr Verhaeltnis zu Stoerungen in der Nierenentwicklung[Juvenille malignant nephrosclerosis and its role in disorders in kidney development]. Acta Pathol Microbiol Scand 1929; 6: 383-42.[CrossRef]
7. Butler AM. Chronic Pyelonephritis and Arterial Hypertension. J Clin Invest 1937; 16: 889-97.[CrossRef]
8. Smith HW. Hypertension and urologic disease. Am J Med 1948; 4: 724-43.[CrossRef]
9. Cohen SL. Hypertension in renal transplant recipients: role of bilateral nephrectomy. Br Med J 1973; 3: 78-81.[CrossRef]
10. McHugh MI, Tanboǧa H, Marcen R, Liano F, Robson V, Wilkinson R. Hypertension following renal transplantation: the role of the host's kidney. Q J Med 1980; 49: 395-403.
11. Ligtenberg G, Blankestijn PJ, Oey PL, Klein IH, Dijkhorst-Oei LT, Boomsma F, et al. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 1999; 340: 1321-8.[CrossRef]
12. Miyajima E, Yamada Y, Yoshida Y, Matsukawa T, Shionoiri H, Tochikubo O, et al. Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism. Hypertension 1991; 17: 1057-62.[CrossRef]
13. Perry CB. Malignant Hypertension Cured by Unilateral Nephrectomy. Br Heart J 1945; 7: 139-42.[CrossRef]
14. Steigerwald K, Titova A, Malle C, Kennerknecht E, Jilek C, Hausleiter J, et al. Morphological assessment of renal arteries after radiofrequency catheter-based sympathetic denervation in a porcine model. J Hypertens 2012; 30: 2230-9.[CrossRef]
15. Rippy MK, Zarins D, Barman NC, Wu A, Duncan KL, Zarins CK. Catheterbased renal sympathetic denervation: chronic preclinical evidence for renal artery safety. Clin Res Cardiol 2011; 100: 1095-101.[CrossRef]
16. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009; 373: 1275-81.[CrossRef]
17. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 2009; 361: 932-4.[CrossRef]
18. Hering D, Lambert EA, Marusic P, Walton AS, Krum H, Lambert GW, et al. Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. Hypertension 2013; 61: 457-64.[CrossRef]
19. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 2011; 57: 911-7.[CrossRef]
20. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M. Renal sympathetic denervation in patients with treatmentresistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010; 376: 1903-9.[CrossRef]
21. Kaltenbach B, Franke J, Bertog SC, Steinberg DH, Hofmann I, Sievert H. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study. Catheter Cardiovasc Interv 2013; 81: 335-9.[CrossRef]
22. Mahfoud F, Cremers B, Janker J, Link B, Vonend O, Ukena C, et al. Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension 2012; 60: 419-24.[CrossRef]
23. Zuern CS, Eick C, Rizas KD, Bauer S, Langer H, Gawaz M,et al. Impaired cardiac baroreflex sensitivity predicts response to renal sympathetic denervation in patients with resistant hypertension. J Am Coll Cardiol 2013; 62: 2124-30.[CrossRef]
24. Hering D, Mahfoud F, Walton AS, Krum H, Lambert GW, Lambert EA, et al. Renal denervation in moderate to severe CKD. J Am Soc Nephrol 2012; 23: 1250-7.[CrossRef]
25. Kaltenbach B, Id D, Franke JC, Sievert H, Hennersdorf M, Maier J, et al. Renal artery stenosis after renal sympathetic denervation. J Am Coll Cardiol 2012; 60: 2694-5.[CrossRef]
26. Vonend O, Antoch G, Rump LC, Blondin D. Secondary rise in blood pressure after renal denervation. Lancet 2012; 380: 778.[CrossRef]
27. Stouffer GA, Dibona GF, Patel A, Kaul P, Hinderliter AL. Catheterbased renal denervation in the treatment of resistant hypertension. J Mol Cell Cardiol 2013; 62: 18-23.[CrossRef]
28. Chinushi M, Izumi D, Iijima K, Suzuki K, Furushima H, Saitoh O, et al. Blood pressure and autonomic responses to electrical stimulation of the renal arterial nerves before and after ablation of the renal artery. Hypertension 2013; 61: 450-6.[CrossRef]
29. Esler M, Lambert G, Jennings G. Regional norepinephrine turnover in human hypertension. Clin Exp Hypertens A 1989; 11: 75-89.[CrossRef]
30. Kaye DM, Esler M, Kingwell B, McPherson G, Esmore D, Jennings G. Functional and neurochemical evidence for partial cardiac sympathetic reinnervation after cardiac transplantation in humans. Circulation 1993; 88: 1110-8.[CrossRef]
31. Gazdar AF, Dammin GJ. Neural degeneration and regeneration in human renal transplants. N Engl J Med 1970; 283: 222-4.[CrossRef]
32. Hansen JM, Abildgaard U, Fogh-Andersen N, Kanstrup IL, Bratholm P, Plum I, et al. The transplanted human kidney does not achieve functional reinnervation. Clin Sci 1994; 87: 13-20.
33. Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, et al. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation 2011; 123: 1940-6.[CrossRef]
34. Schlaich MP, Straznicky N, Grima M, Ika-Sari C Dawood T, Mahfoud F, et al. Renal denervation: a potential new treatment modality for polycystic ovary syndrome? J Hypertens 2011; 29: 991-6.[CrossRef]
35. Witkowski A, Prejbisz A, Florczak E, Kadziela J, Śliwiński P, Bieleń P, et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension 2011; 58: 559-65.[CrossRef]
36. Koistinen HA, Zierath JR. Regulation of glucose transport in human skeletal muscle. Ann Med 2002; 34: 410-8.[CrossRef]
37. Luippold G, Beilharz M, Muhlbauer B. Chronic renal denervation prevents glomerular hyperfiltration in diabetic rats. Nephrol Dial Transplant 2004; 19: 342-7.[CrossRef]
38. Mogensen CE. Glomerular filtration rate and renal plasma flow in normal and diabetic man during elevation of blood sugar levels. Scand J Clin Lab Invest 1971; 28: 177-82.[CrossRef]
39. Christiansen JS, Gammelgaard J, Tronier B, Svendsen PA, Parving HH. Kidney function and size in diabetics before and during initial insulin treatment. Kidney Int 1982; 21: 683-8.[CrossRef]
40. Ukena C, Mahfoud F, Linz D, Bohm M, Neuberger HR. Potential role of renal sympathetic denervation for the treatment of cardiac arrhythmias. EuroIntervention 2013; 9: 110-6.
41. Pokushalov E, Romanov A, Corbucci G, Artyomenko S, Baranova V, Turov A, et al. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol 2012; 60: 1163-70.[CrossRef]
42. Brandt MC, Mahfoud F, Reda S, Schirmer SH, Erdmann E, Bohm M, et al. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol 2012; 59: 901-9.[CrossRef]
43. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 1986; 73: 615-21.[CrossRef]
44. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311: 819-23.[CrossRef]
45. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344: 1651-8.[CrossRef]
46. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 1987; 316: 1429-35.[CrossRef]
47. Nozawa T, Igawa A, Fujii N, Kato B, Yoshida N, Asanoi H, et al. Effects of long-term renal sympathetic denervation on heart failure after myocardial infarction in rats. Heart Vessels 2002; 16: 51-6.[CrossRef]
48. Chen SL, Zhang FF, Xu J, Xie DJ, Zhou L, Nguyen T, et al. Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man padn-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension). J Am Coll Cardiol 2013; 62: 1092-100.[CrossRef]